Annual Operating Profit
-$466.57 M
-$244.03 M-109.66%
December 31, 2024
Summary
- As of March 7, 2025, CRSP annual operating income is -$466.57 million, with the most recent change of -$244.03 million (-109.66%) on December 31, 2024.
- During the last 3 years, CRSP annual operating profit has fallen by -$840.09 million (-224.91%).
- CRSP annual operating profit is now -224.91% below its all-time high of $373.53 million, reached on December 31, 2021.
Performance
CRSP Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Profit
-$64.59 M
+$45.54 M+41.35%
December 31, 2024
Summary
- As of March 7, 2025, CRSP quarterly operating income is -$64.59 million, with the most recent change of +$45.54 million (+41.35%) on December 31, 2024.
- Over the past year, CRSP quarterly operating profit has increased by +$86.67 million (+57.30%).
- CRSP quarterly operating profit is now -108.47% below its all-time high of $762.62 million, reached on June 30, 2021.
Performance
CRSP Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Operating Profit
-$466.56 M
-$134.17 M-40.37%
December 31, 2024
Summary
- As of March 7, 2025, CRSP TTM operating income is -$466.56 million, with the most recent change of -$134.17 million (-40.37%) on December 31, 2024.
- Over the past year, CRSP TTM operating profit has dropped by -$111.89 million (-31.55%).
- CRSP TTM operating profit is now -204.16% below its all-time high of $447.92 million, reached on June 30, 2021.
Performance
CRSP TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
CRSP Operating Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -109.7% | +57.3% | -31.6% |
| 3 y3 years | -224.9% | +57.3% | -31.6% |
| 5 y5 years | -1098.2% | +57.3% | -31.6% |
CRSP Operating Profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -224.9% | +30.7% | -192.8% | +64.8% | -224.9% | +32.1% |
| 5 y | 5-year | -224.9% | +30.7% | -108.5% | +64.8% | -204.2% | +32.1% |
| alltime | all time | -224.9% | +30.7% | -108.5% | +64.8% | -204.2% | +32.1% |
CRISPR Therapeutics AG Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$466.57 M(+109.7%) | -$64.59 M(-41.4%) | -$466.56 M(+40.4%) |
| Sep 2024 | - | -$110.13 M(-27.2%) | -$332.39 M(-6.3%) |
| Jun 2024 | - | -$151.26 M(+7.6%) | -$354.68 M(+18.8%) |
| Mar 2024 | - | -$140.59 M(-302.0%) | -$298.64 M(+34.2%) |
| Dec 2023 | -$222.54 M(-66.9%) | $69.58 M(-152.6%) | -$222.54 M(-47.5%) |
| Sep 2023 | - | -$132.41 M(+39.1%) | -$423.66 M(-10.6%) |
| Jun 2023 | - | -$95.22 M(+47.7%) | -$473.64 M(-15.7%) |
| Mar 2023 | - | -$64.49 M(-51.0%) | -$561.68 M(-16.6%) |
| Dec 2022 | -$673.16 M(-280.2%) | -$131.54 M(-27.9%) | -$673.16 M(-2.1%) |
| Sep 2022 | - | -$182.39 M(-0.5%) | -$687.32 M(+8.4%) |
| Jun 2022 | - | -$183.26 M(+4.1%) | -$633.78 M(-303.1%) |
| Mar 2022 | - | -$175.97 M(+20.8%) | $312.10 M(-16.4%) |
| Dec 2021 | $373.53 M(-205.4%) | -$145.70 M(+13.1%) | $373.53 M(-9.2%) |
| Sep 2021 | - | -$128.85 M(-116.9%) | $411.46 M(-8.1%) |
| Jun 2021 | - | $762.62 M(-765.8%) | $447.92 M(-213.3%) |
| Mar 2021 | - | -$114.54 M(+6.3%) | -$395.39 M(+11.6%) |
| Dec 2020 | -$354.44 M | -$107.76 M(+16.6%) | -$354.44 M(+50.4%) |
| Sep 2020 | - | -$92.40 M(+14.5%) | -$235.69 M(+5608.2%) |
| Jun 2020 | - | -$80.69 M(+9.7%) | -$4.13 M(-119.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | - | -$73.59 M(-770.0%) | $21.58 M(-53.8%) |
| Dec 2019 | $46.74 M(-129.4%) | $10.98 M(-92.1%) | $46.74 M(-593.5%) |
| Sep 2019 | - | $139.16 M(-353.1%) | -$9.47 M(-95.2%) |
| Jun 2019 | - | -$54.98 M(+13.5%) | -$198.07 M(+9.8%) |
| Mar 2019 | - | -$48.42 M(+7.1%) | -$180.37 M(+13.5%) |
| Dec 2018 | -$158.94 M(+145.9%) | -$45.23 M(-8.5%) | -$158.94 M(+41.0%) |
| Sep 2018 | - | -$49.43 M(+32.6%) | -$112.74 M(+29.8%) |
| Jun 2018 | - | -$37.29 M(+38.1%) | -$86.88 M(+22.5%) |
| Mar 2018 | - | -$27.00 M(-2877.5%) | -$70.90 M(+9.7%) |
| Dec 2017 | -$64.65 M(-5.1%) | $972.00 K(-104.1%) | -$64.65 M(-28.9%) |
| Sep 2017 | - | -$23.57 M(+10.6%) | -$90.93 M(+10.9%) |
| Jun 2017 | - | -$21.31 M(+2.7%) | -$81.97 M(+6.1%) |
| Mar 2017 | - | -$20.74 M(-18.0%) | -$77.22 M(+13.3%) |
| Dec 2016 | -$68.13 M(+164.8%) | -$25.31 M(+73.2%) | -$68.13 M(+23.9%) |
| Sep 2016 | - | -$14.61 M(-11.8%) | -$54.99 M(+18.1%) |
| Jun 2016 | - | -$16.56 M(+42.1%) | -$46.58 M(+55.2%) |
| Mar 2016 | - | -$11.65 M(-4.2%) | -$30.02 M(+63.4%) |
| Dec 2015 | -$25.73 M(+288.2%) | -$12.17 M(+96.2%) | -$18.37 M(+196.2%) |
| Sep 2015 | - | -$6.20 M | -$6.20 M |
| Dec 2014 | -$6.63 M | - | - |
FAQ
- What is CRISPR Therapeutics AG annual operating income?
- What is the all time high annual operating profit for CRISPR Therapeutics AG?
- What is CRISPR Therapeutics AG annual operating profit year-on-year change?
- What is CRISPR Therapeutics AG quarterly operating income?
- What is the all time high quarterly operating profit for CRISPR Therapeutics AG?
- What is CRISPR Therapeutics AG quarterly operating profit year-on-year change?
- What is CRISPR Therapeutics AG TTM operating income?
- What is the all time high TTM operating profit for CRISPR Therapeutics AG?
- What is CRISPR Therapeutics AG TTM operating profit year-on-year change?
What is CRISPR Therapeutics AG annual operating income?
The current annual operating profit of CRSP is -$466.57 M
What is the all time high annual operating profit for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high annual operating income is $373.53 M
What is CRISPR Therapeutics AG annual operating profit year-on-year change?
Over the past year, CRSP annual operating income has changed by -$244.03 M (-109.66%)
What is CRISPR Therapeutics AG quarterly operating income?
The current quarterly operating profit of CRSP is -$64.59 M
What is the all time high quarterly operating profit for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high quarterly operating income is $762.62 M
What is CRISPR Therapeutics AG quarterly operating profit year-on-year change?
Over the past year, CRSP quarterly operating income has changed by +$86.67 M (+57.30%)
What is CRISPR Therapeutics AG TTM operating income?
The current TTM operating profit of CRSP is -$466.56 M
What is the all time high TTM operating profit for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high TTM operating income is $447.92 M
What is CRISPR Therapeutics AG TTM operating profit year-on-year change?
Over the past year, CRSP TTM operating income has changed by -$111.89 M (-31.55%)